Furthermore, increased levels of IL-6 were correlated with poorer prognosis in many cancer types, including breast cancer, prostate cancer, metastatic CRC, MM, and non-small cell lung cancer (NSCL] [184,186,187,188,189,190]. This evidence concerns the gene IL6 and breast cancer.